Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.
Although the increase in risk of developing breast, ovarian, and prostate cancer in BRCA1 and BRCA2 mutation carriers has been studied extensively, its impact on mortality is not well quantified. Further, possible effect of BRCA mutations on non-cancer mortality risk has not been examined.Using mort...
Main Authors: | Phuong L Mai, Nilanjan Chatterjee, Patricia Hartge, Margaret Tucker, Lawrence Brody, Jeffery P Struewing, Sholom Wacholder |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2652075?pdf=render |
Similar Items
-
Genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
by: Kuchenbaecker, Karoline Bernhardine Elisabeth Karla Ursula
Published: (2015) -
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
by: Rachel Mitchell, et al.
Published: (2018-01-01) -
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2017-01-01) -
Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors
by: Ciara C. O'Sullivan, et al.
Published: (2014-02-01) -
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes
by: Rutter Joni L, et al.
Published: (2004-03-01)